1302276

Inspection Details

Classification

No Action Indicated (NAI) (NAI)

End Date

January 30, 2026

Fiscal Year

2026

Product Type

Drugs

Project Area

Bioresearch Monitoring

Location

Philadelphia, PA (United States)

Additional Details